These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8081009)

  • 1. Rapid massive splenic relapse of hairy cell leukemia (HCL) during bone marrow remission after 2-chlorodeoxyadenosine therapy: the spleen as a sanctuary site in HCL?
    Polliack A; Dann EJ
    Blood; 1994 Sep; 84(6):2057-8. PubMed ID: 8081009
    [No Abstract]   [Full Text] [Related]  

  • 2. Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine.
    Piro LD; Carrera CJ; Carson DA; Beutler E
    N Engl J Med; 1990 Apr; 322(16):1117-21. PubMed ID: 1969613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of complete remission after 2-chlorodeoxyadenosine for hairy cell leukemia: utility of marrow immunostaining and measurement of splenic index.
    Tallman MS; Hakimian D; Dyrda S; Kiley C; Nemcek A; Peterson L
    Leuk Lymphoma; 1994; 14 Suppl 1():133-8. PubMed ID: 7529609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-lasting complete remission in patients with hairy cell leukemia treated with 2-CdA: a 5-year survey.
    Lauria F; Rondelli D; Zinzani PL; Bocchia M; Marotta G; Salvucci M; Raspadori D; Ventura MA; Birtolo S; Forconi F; Tura S
    Leukemia; 1997 May; 11(5):629-32. PubMed ID: 9180283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hairy cell leukemia and variant in Taiwan: report of a variant case and literature review.
    Hsieh YC; Chang ST; Chuang SS; Lu CL; Tsao CJ; Lin CN; Li CY
    Int J Clin Exp Pathol; 2011 Jan; 4(2):183-9. PubMed ID: 21326814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bone marrow changes in patients with hairy cell leukemia after 2-chlorodeoxyadenosine treatment].
    Urasiński I; Zdziarska B; Krygier-Stojałowska A
    Acta Haematol Pol; 1996; 27(1):49-55. PubMed ID: 8629443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow trephines. Findings in patients with hairy cell leukaemia before and after treatment.
    Pittaluga S; Verhoef G; Maes A; Boogaerts MA; De Wolf-Peeters C
    Histopathology; 1994 Aug; 25(2):129-35. PubMed ID: 7982675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in therapy for hairy cell leukemia. A review.
    Jaiyesimi IA; Kantarjian HM; Estey EH
    Cancer; 1993 Jul; 72(1):5-16. PubMed ID: 7685243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimal residual disease in hairy-cell leukemia after treatment with 2-chlorodeoxyadenosine.
    Konwalinka G; Schirmer M; Hilbe W; Fend F; Geisen F; Knoblechner A; Petzer A; Thaler J
    Blood Cells Mol Dis; 1995; 21(2):142-51. PubMed ID: 8846043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunohistochemical detection and quantification of minimal residual disease using DBA.44 antibodies in trephination biopsies of hairy cell leukemia].
    Dĕdic K; Zák P
    Cesk Patol; 2003 Oct; 39(4):175-7. PubMed ID: 14663929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA).
    Estey EH; Kurzrock R; Kantarjian HM; O'Brien SM; McCredie KB; Beran M; Koller C; Keating MJ; Hirsch-Ginsberg C; Huh YO
    Blood; 1992 Feb; 79(4):882-7. PubMed ID: 1346577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Chlorodeoxyadenosine: hairy cell leukemia takes a surprising turn.
    Beutler E; Carson DA
    Blood Cells; 1993; 19(3):559-68; discussion 569-72. PubMed ID: 8018939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomorphologic analysis of bone marrow biopsies after treatment with 2-chlorodeoxyadenosine for hairy cell leukemia.
    Ellison DJ; Sharpe RW; Robbins BA; Spinosa JC; Leopard JD; Saven A; Piro LD
    Blood; 1994 Dec; 84(12):4310-5. PubMed ID: 7994047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of minimal residual disease by immunostaining of bone marrow biopsies after 2-chlorodeoxyadenosine for hairy cell leukemia.
    Hakimian D; Tallman MS; Kiley C; Peterson L
    Blood; 1993 Sep; 82(6):1798-802. PubMed ID: 7691237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow granulomas in hairy cell leukaemia following 2-chlorodeoxyadenosine therapy.
    Franco V; Florena AM; Quintini G; Musso M
    Histopathology; 1994 Mar; 24(3):271-3. PubMed ID: 7911119
    [No Abstract]   [Full Text] [Related]  

  • 16. Five years follow-up after 2-chloro deoxyadenosine treatment in thirty patients with hairy cell leukemia: evaluation of minimal residual disease and CD4+ lymphocytopenia after treatment.
    Bastie JN; Cazals-Hatem D; Daniel MT; D'Agay MF; Rabian C; Glaisner S; Noel-Walter MP; Dabout D; Flandrin G; Dombret H; Poisson D; Degos L; Castaigne S
    Leuk Lymphoma; 1999 Nov; 35(5-6):555-65. PubMed ID: 10609793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of aplastic variant of hairy-cell leukaemia with deoxycoformycin.
    Ng JP; Nolan B; Chan-Lam D; Coup AJ; McKenna D
    Hematology; 2002 Aug; 7(4):259-62. PubMed ID: 14972788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow histology in patients with hairy cell leukemia (HCL) treated by human lymphoblastoid interferon.
    Coci A; Castello A; Pagnucco G; Magrini U; Merante S; Brusamolino E; Castelli G; Canevari A; Bernasconi C
    Haematologica; 1987; 72(2):143-9. PubMed ID: 3114069
    [No Abstract]   [Full Text] [Related]  

  • 19. Bone marrow in hairy cell leukemia.
    Katayama I
    Hematol Oncol Clin North Am; 1988 Dec; 2(4):585-602. PubMed ID: 3065320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete remission of hairy cell leukemia variant (HCL-v) complicated by red cell aplasia post treatment with rituximab.
    Quach H; Januszewicz H; Westerman D
    Haematologica; 2005 Nov; 90 Suppl():ECR26. PubMed ID: 16266917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.